Studies of TMPRSS2-ERG gene fusions in diagnostic trans-rectal prostate biopsies [1]

Clinical Cancer Research

Volumn 16, Issue 4, 2010, Pages 1340-

  Attard, Gerhardt ^a   De Bono, Johann S ^a   Clark, Jeremy ^a   Cooper, Colin S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR ERG; ERG PROTEIN, HUMAN; ONCOPROTEIN; SERINE PROTEINASE; TMPRSS2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC TEST; DISEASE COURSE; GENE FUSION; GENE REARRANGEMENT; HUMAN; LETTER; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TMPRSS2 ERG GENE; TRANS RECTAL PROSTATE BIOPSY; TRANSURETHRAL RESECTION; TUMOR GENE; UNITED STATES; BIOPSY; GENE TRANSLOCATION; GENETICS; MALE; METHODOLOGY; NOTE; PATHOLOGY; PROSTATE TUMOR;

BIOPSY; HUMANS; MALE; ONCOGENE PROTEINS, FUSION; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES; TRANS-ACTIVATORS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 76749121995     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2253     Document Type: Letter

References (5)

1. Mosquera JM, Mehra R, Regan MM, et al. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res 2009.
2. Attard G, Clark J, Ambroisine L, et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008;27:253-63.
3. Clark JP, Cooper CS. ETS gene fusions in prostate cancer. Nat Rev Urol 2009;6:429-39.
4. Attard G, Swennenhuis JF, Olmos D, et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009;69:2912-8.
5. Guo CC, Zuo G, Cao D, Troncoso P, Czerniak BA. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol 2009;22:866-71.